ADMA Biologics
ADMA
ADMA
74 hedge funds and large institutions have $130M invested in ADMA Biologics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.
Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
32
Reduced
15
Closed
13
Calls
$107K
Puts
$128K
Net Calls
-$21K
Net Calls Change
-$286K
Top Buyers
1 |
1
BlackRock
New York
|
$15.9M |
2 |
SFM
2
Sphera Funds Management
Tel Aviv,
Israel
|
$2.16M |
3 |
3
Goldman Sachs
New York
|
$1.41M |
4 |
4
State Street
Boston,
Massachusetts
|
$3.37M |
5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$1.12M |